{"organizations": ["Volk Optical", "Caris Molecular Intelligence", "Heart Failure Society of America Annual Meeting", "Lilly", "Congress", "MCG", "Medical College of Georgia", "Palatin Technologies, Inc.", "Alliance Healthcare Foundation", "The University of Texas M. D. Anderson Cancer", "Eli Lilly", "Sharon Blank", "University of Miami", "Mirati Therapeutics, Inc.", "University of Colorado", "San Diego ... Mountain Health & Community Services", "Amica", "Cardiovascular Institute", "Biomoda, Inc.", "U.S. Patent Office Grants Biomoda Registration for Trademarks Compromised US and Chinese Computers Launch Greatest Number of Cyber Attacks", "Presbyterian Retirement Services", "CCS", "Ohio Presbyterian Retirement Services", "Mirati Therapeutics Presents Interim Clinical Data"], "uuid": "5f2843cb7e7cf6e5e2c94727886ffbeda4f358df", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.bio-medicine.org", "main_image": "", "site_section": "http://www.bio-medicine.org/inc/biomed/medicine-technology.asp", "section_title": "Latest Medical Technology from Bio-Medicine.Org", "url": "http://www.bio-medicine.org/medicine-technology-1/Caris-Molecular-Intelligence-Tumor-Profiling-Identifies-Potential-Responders-to-Anticancer-Therapy-Across-a-Range-of-Tumor-Types-48411-1/", "country": "US", "title": "Caris Molecular Intelligence Tumor Profiling Identifies Potential Responders to Anticancer Therapy Across a Range of Tumor Types", "performance_score": 0, "site": "bio-medicine.org", "participants_count": 0, "title_full": "Caris Molecular Intelligence Tumor Profiling Identifies Potential Responders to Anticancer Therapy Across a Range of Tumor Types", "spam_score": 0.0, "site_type": "news", "published": "2015-09-28T19:13:00.000+03:00", "replies_count": 0, "uuid": "5f2843cb7e7cf6e5e2c94727886ffbeda4f358df"}, "author": "", "url": "http://www.bio-medicine.org/medicine-technology-1/Caris-Molecular-Intelligence-Tumor-Profiling-Identifies-Potential-Responders-to-Anticancer-Therapy-Across-a-Range-of-Tumor-Types-48411-1/", "ord_in_thread": 0, "title": "Caris Molecular Intelligence Tumor Profiling Identifies Potential Responders to Anticancer Therapy Across a Range of Tumor Types", "locations": ["America", "US", "BRIDGEWATER", "U.S.", "HANOVER", "TORONTO", "R.I.", "Austria", "N.J.", "Vienna", "San Antonio", "Ohio"], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": ["Biomoda", "John Cousins", "Krishnan Dhandapani", "Bristow", "Michael Bristow", "Michael R. Bristow"], "text": "  , Sept. 28, 2015 Eli Lilly and ... settlement agreement to resolve patent   ... the agreement, Lilly and its   ... U.S. on December 15, 2016. Under the terms of ... so Lilly can manufacture and sell Basaglar in the ... (Date:9/28/2015)... 2015 Palatin Technologies, Inc. (NYSE MKT: ... peptide therapeutics for the treatment of diseases ... potential, today announced that a poster entitled ... cardiac hypertrophy and pro-fibrotic gene activation in ... novel selective GC-A receptor peptide agonist rescues   Mirati Therapeutics, Inc. (\"Mirati\") ... genetic and epigenetic drivers of cancer, today announced it ... 1/1b Study of Receptor Tyrosine Kinase (RTK) Inhibitor, MGCD516, ... European Cancer Congress (ECC) in Vienna, Austria ... this weekend provide initial clinical evidence of MGCD516,s safety ... [   Preclinical Data on PL-3994 for Heart Failure and Resistant Hypertension Presented at 2015 Heart Failure Society of America Annual Meeting [ 0 ] Mirati Therapeutics Presents Interim Clinical Data From Ongoing MGCD516 Phase 1 Dose Escalation Study In Patients With Advanced Solid Tumors ... BRIDGEWATER, N.J., Dec. 9, 2010 Sanofi-aventis ... today that the final survival analysis (10-year follow-up) of ... Concentrate chemotherapy treatment regimen in the adjuvant breast cancer ... and clinical breast cancer studies will be featured during ... ... HANOVER, N.J., Dec. 9, 2010 A new ... tablets) to the hormonal therapy tamoxifen in patients ... (HR+/HER2-) metastatic breast cancer who have been previously ... progression compared to tamoxifen alone. These results were ... Sanofi-aventis Oncology Data to be Presented at San Antonio Breast Cancer Symposium Study Shows Novartis Drug AfinitorÂ® Plus Hormonal Therapy Delays Disease Progression in Advanced Metastatic Breast Cancer Patients (Date:  Ohio Presbyterian Retirement Services (OPRS) is ... innovative Home to Stay program to help patients discharged from hospitals stay healthy at ... Presbyterian Retirement Services (OPRS). Health measurements are taken at home and data goes to ... (Date:  Language Scientific, ... announce Sharon Blank as its new CEO as of September 16th, 2015. Most ... brings 20 plus years of global sales expertise and a strong background of ... (Date:9/28/2015)... (PRWEB) , ... September 28, 2015 , ... ... advance health and wellness for the poor and underserved in the San Diego ... Mountain Health & Community Services (MHCS) as the recipient of its $1 million ... (Date:9/28/2015)... LINCOLN, R.I. (PRWEB) , ... September 28, 2015 , ... Falling can have a serious ... an older adult is treated in the emergency room for a fall, according to the ... is offering tips to increase safety and reduce the chances of falling in or ... (Date:9/28/2015)... ... ... ABTS Convention Services (ABTS) , together with the University of Miami ... joint venture to analyze variables/factors that affect annual meeting attendance in an effort to ... UM CCS have been collecting relevant large scale data sets within the US and ... [ 0 ] Ohio Presbyterian Retirement Services Expands Its Innovative Home To Stay Program for Seniors In Ohio [ 0 ] Language Scientific Announces New Chief Executive Officer [ 0 ] Alliance Healthcare Foundation Announces $1 Million Award for its 2015 Innovation Initiative [ 0 ] Fall Prevention: Amica Has 6 Tips to Improve Safety in the Home [ 0 ] ABTS Convention Services Launches Project Pythia. ... Sept. 22 Biomoda, Inc.,(OTC Bulletin Board: BMOD) ... expanded its intellectual property portfolio,with approval from the ... and CyPath(R)., \"We are pleased to receive ... portfolio,\" said John Cousins, Biomoda president. \"It is ... ... Organizations and Individuals Need to Enhance Computer Security, ... the market,s,leading Security-as-a-Service (SaaS) providers, has published the ... of cyber attacks were,attempted against its clients in ... million attempted attacks originating from computers within the,country ... ... Ill. September 22, 2008 A study appearing ... Journal of Medicine shows that among individuals with no ... risk of colorectal cancer is extremely low. The data provides ... longer after a normal colonoscopic examination. , \"This research is ... ... want to make curcumin part of your daily diet. ... spice, turmeric, not only lowers your chances of getting ... of a hemorrhagic stroke, say Medical College of Georgia ... with Dr. Krishnan Dhandapani, neuroscientist in the MCG School ... ... (SRS) and whole brain radiation therapy (WBRT) for the ... the risk of developing learning and memory problems than ... from The University of Texas M. D. Anderson Cancer ... trial were presented at today,s 50th annual meeting of ... ... Honors Michael R. Bristow, M.D., Ph.D., TORONTO, ... America,(HFSA) announced today that Michael Bristow, M.D., Ph.D., ... University of Colorado,Cardiovascular Institute, is the recipient of ... presented to Bristow at the Opening,Plenary Session of ... U.S. Patent Office Grants Biomoda Registration for Trademarks Compromised US and Chinese Computers Launch Greatest Number of Cyber Attacks, According to SecureWorks' Data Risk of colorectal cancer extremely low 5 years after a normal colonoscopy screening Indian spice reduces size of hemorrhagic stroke Whole brain radiation increases risk of learning and memory problems in cancer patients 2008 Lifetime Achievement Award in Heart Failure Presented During HFSA Annual Scientific Meeting ... Traditionally, when choosing a non-contact diagnostic lens, doctors ... field of view and high magnification. Now, ... by Volk Optical, doctors can have both in ... field of view available in a non-contact lens ... ... C-VUE 55 Toric Multifocal soft lens ... presbyopia with all day comfort, ease ... at every distance. This brand new ... of parameters with ADDs up to ... ... Leica M844 F40 with its new stand F19 ... allow on the one hand to homogenously move ... operate with a solid and stable microscope. The ... Chrome optics, stands on the same small footprint ... ... a high-throughput immunoassay system built around the ... with the important addition of Logic Driven ... be designed for optimal performance with the ... critical assays such as the cardiac biomarkers ...", "external_links": [], "published": "2015-09-28T19:13:00.000+03:00", "crawled": "2015-09-28T20:54:11.047+03:00", "highlightTitle": ""}